Provide Answers About GLP-1 Agonists for Weight Loss

July 2024

High demand and persistent shortages are leading to questions about the weight loss meds semaglutide (Wegovy) and tirzepatide (Zepbound).

Is it okay to switch to a different GLP-1 agonist? In some cases.

Keep in mind, semaglutide or tirzepatide seem to be the most effective meds for managing overweight or obesity.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Obesity & Weight Loss Provide Answers About GLP-1 Agonists for Weight Loss
Dermatology Identify Med Culprits of Dermatologic Emergencies
Education and Training Help Learners and Colleagues Conquer Impostor Syndrome
Liver Disease Watch for Resmetirom to Treat NASH
Ophthalmology Navigate Options for Acute Conjunctivitis
Infectious Diseases Stay Alert for Rising Rates of Bacterial Meningitis
Appropriate Med Use Watch for Deprescribing Opportunities
NatMed Spotlight Be Ready for Questions About Shilajit